Literature DB >> 18292547

Modifications in small interfering RNA that separate immunostimulation from RNA interference.

Florian Eberle1, Kerstin Giessler, Christopher Deck, Klaus Heeg, Mirjam Peter, Clemens Richert, Alexander H Dalpke.   

Abstract

Synthetic small interfering RNA (siRNA) can suppress the expression of endogenous mRNA through RNA interference. It has been reported that siRNA can induce type I IFN production from plasmacytoid dendritic cells, leading to off-target effects. To separate immunostimulation from the desired gene-specific inhibitory activity, we designed RNA strands with chemical modifications at strategic positions of the ribose or nucleobase residues. Substitution of uridine residues by 2'-deoxyuridine or thymidine residues was found to decrease type I IFN production upon in vitro stimulation of human PBMC. Thymidine residues in both strands of a siRNA duplex further decreased immunostimulation. Fortunately, the thymidine residues did not affect gene-silencing activity. In contrast, 2'-O-methyl groups at adenosine and uridine residues reduced both IFN-alpha secretion and gene-silencing activity. Oligoribonucleotides with 2'-O-methyladenosine residues actively inhibited IFN-alpha secretion induced by other immunostimulatory RNAs, an effect not observed for strands with 2'-deoxynucleosides. Furthermore, neither 5-methylcytidine nor 7-deazaguanosine residues in the stimulatory strands affected IFN-alpha secretion, suggesting that recognition does not involve sites in the major groove of duplex regions. The activity data, together with structure prediction and exploratory UV-melting analyses, suggest that immunostimulatory sequences adopt folded structures. The results show that immunostimulation can be suppressed by suitable chemical modifications without losing siRNA potency by introducing seemingly minor structural changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292547     DOI: 10.4049/jimmunol.180.5.3229

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.

Authors:  Sibylle Tluk; Marion Jurk; Alexandra Forsbach; Risini Weeratna; Ulrike Samulowitz; Arthur M Krieg; Stefan Bauer; Jörg Vollmer
Journal:  Int Immunol       Date:  2009-03-30       Impact factor: 4.823

2.  A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery.

Authors:  David N Nguyen; Phillip Kim; Luis Martínez-Sobrido; Brett Beitzel; Adolfo García-Sastre; Robert Langer; Daniel G Anderson
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

Review 3.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

Review 4.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

Review 5.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

Review 6.  Chemical modification of siRNA bases to probe and enhance RNA interference.

Authors:  Hayden Peacock; Arunkumar Kannan; Peter A Beal; Cynthia J Burrows
Journal:  J Org Chem       Date:  2011-08-17       Impact factor: 4.354

7.  Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery.

Authors:  David N Nguyen; Kerry P Mahon; Ghania Chikh; Phillip Kim; Hattie Chung; Alain P Vicari; Kevin T Love; Michael Goldberg; Steve Chen; Arthur M Krieg; Jianzhu Chen; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

8.  Weak base pairing in both seed and 3' regions reduces RNAi off-targets and enhances si/shRNA designs.

Authors:  Shuo Gu; Yue Zhang; Lan Jin; Yong Huang; Feijie Zhang; Michael C Bassik; Martin Kampmann; Mark A Kay
Journal:  Nucleic Acids Res       Date:  2014-09-30       Impact factor: 16.971

9.  Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA.

Authors:  Hayden Peacock; Raymond V Fucini; Prasanna Jayalath; José M Ibarra-Soza; Henry J Haringsma; W Michael Flanagan; Aarron Willingham; Peter A Beal
Journal:  J Am Chem Soc       Date:  2011-06-01       Impact factor: 15.419

10.  Drug delivery-mediated control of RNA immunostimulation.

Authors:  David N Nguyen; Steve C-Y Chen; James Lu; Michael Goldberg; Phillip Kim; Andrew Sprague; Tatiana Novobrantseva; Jennifer Sherman; Svetlana Shulga-Morskaya; Antonin de Fougerolles; Jianzhu Chen; Robert Langer; Daniel G Anderson
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.